|
|
|
|
|
|
Significance of interleukin-1 and interleukin-2 in pathogeny ofsystemic scleroderma
Ye.M.Neyko R.I.Yatsyshyn
Ivano-Frankivsk Medical Academy
Abstract
The purpose of a research was to define the levels of
interleukin-1 (IL-1) and interleukin-2 (IL-2) in patients
with systemic scleroderma (SSc) and to analyse
their dependence on the course of the illness. 75 paticnts
with SSc and 20 apparently healthy people were
examined. Besides the well-known clinical-biochemical
and instrumental investigations, the levels of IL-1
and Il-2 in all the patients were determined in serum
with an immunoenzymatic method using a set of reactants
Pro Con IL-1b and Pro Con IL-2 (Russia). The
data obtained give evidence for an increase in both
IL-1 and IL-2 levels. As the correlation between the
level of IL-1 and the acuteness of the pathological
process has been shown to be especially distinct, it
can be used for marking an acute form of this pathology.
Thus, both parametres (IL-1, IL-2) depend
on the acuity and peculiarities of SSc, and on the
concomitant damage of the internal organs. The most
pronounced increase in LL-2 level has been observed
at visceralisation of SSc.
References
- Возианов А.Ф., Бутенко А.К., Зак А.П. Цитокины: биологические и противоопухолевые средства.-К.: Наук. думка, 1998. - 314 с.
- Гусева Н.Г. Системная склеродермия и псевдосклеродермические синдромы. - М.:Медицина,1993. - 268 с.
- Дранник Г.Н. Клиническая иммунология и аллергология. - Одесса: Астропринт, 1999. - 604 c.
- Клиническая иммунология и аллергология / Подред.Л.Йегера.-2-е изд.:Пер.с нем. - М.:Медицина, 1990. - Т. 2. - 345 с.
- Нейко Є.М., Александрук О.Д., Островський М.М. Фізіологія цитокінів // Галицьк. лікар.вісник. - 2000. - 7, № 4. - C.153-158.
- Ревматические болезни / Руководство для врачей / Под ред. В.А.Насоновой, Н.В.Бунчука. -М.: Медицина,1997. - 520 с.
- Needleman BW, Wigley FM, Stair RW. Interleukin-1,interleukin-2, interleukin-4, interleukin-6, tumornecrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma //Arthritis Rheum.-1992. - 35, N 1. - P.67-72.
- Needleman BW. Immunologic aspects of scleroderma// Curr. Opin. Rheumatol. - 1992. - 4, N 6. -P.862-868.
- 9. Rubin L.A. The soluble interleukin-2 receptor in rheumatic disease // Arthr.Rheum. - 1990. - 33.- P.1145-1148.
- 10. Smith EA. Connective tissue metabolism including cytokines in scleroderma. // Curr. Opin. Rheumatol. - 1992. - 4, N 6. - P.869-877.
|
|
|
|
|
|
|
© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.
|
|